Cynthia Heck
Psychiatric/Mental Health · Kansas City, MONPI 1659825511
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 505 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 505 payments — averaging $17.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Alkermes, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$915
- Teva Pharmaceuticals USA, Inc.$911
- Sunovion Pharmaceuticals Inc.$579
- plus $2K from 10 others
What the payments were for
- Food & beverage$8,62498%
- Education$1362%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 115 | $1,935 |
| Otsuka America Pharmaceutical, Inc. | 67 | $1,334 |
| Alkermes, Inc. | 56 | $1,214 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 68 | $915 |
| Teva Pharmaceuticals USA, Inc. | 72 | $911 |
| Sunovion Pharmaceuticals Inc. | 35 | $579 |
| Axsome Therapeutics, Inc. | 16 | $409 |
| E.r. Squibb & Sons, L.L.C. | 12 | $393 |
| Johnson & Johnson | 15 | $244 |
| Neurocrine Biosciences, Inc. | 12 | $214 |
| Lundbeck LLC | 14 | $212 |
| Vanda Pharmaceuticals Inc. | 8 | $161 |
| Indivior Inc. | 6 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $78 |
| Biogen | 2 | $32 |
| Almatica Pharma LLC | 2 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$502
- REXULTI$291
- Auvelity$228
- COBENFY$219
- CAPLYTA$120
- ABILIFY MAINTENA$118
- ABILIFY ASIMTUFII$118
How this compares
$8,761 in reported general payments places this provider in the 95th percentile of 565 psychiatric/mental health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 26 | $239,779 |
| IngrezzaValbenazine Tosylate | 29 | $235,250 |
| Abilify MaintenaAripiprazole | 59 | $167,630 |
| Invega SustennaPaliperidone Palmitate | 33 | $120,467 |
| Invega TrinzaPaliperidone Palmitate | 15 | $115,052 |
| Austedo XrDeutetrabenazine | 14 | $107,117 |
| RexultiBrexpiprazole | 65 | $100,184 |
| Abilify AsimtufiiAripiprazole | 14 | $84,052 |
| VraylarCariprazine Hcl | 48 | $67,110 |
| TrintellixVortioxetine Hydrobromide | 102 | $51,615 |
| CaplytaLumateperone Tosylate | 29 | $47,239 |
| AristadaAripiprazole Lauroxil | 12 | $34,063 |
| Risperdal ConstaRisperidone Microspheres | 12 | $21,768 |
| Lurasidone Hcl | 76 | $7,175 |
| Paliperidone ErPaliperidone | 95 | $7,130 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti, Abilify Asimtufii | $1,334 | $351,866138 claims |
| Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr, Loxapine | $911 | $348,22164 claims |
| Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta | $244 | $257,28760 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $214 | $235,25029 claims |
| AbbVieVraylar | $1,935 | $67,11048 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $78 | $51,615102 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $915 | $47,23929 claims |
| Alkermes, Inc.Aristada | $1,214 | $34,06312 claims |
| Almatica Pharma LLCSertraline Hcl | $28 | $1,705176 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 565 psychiatric/mental health providers in Missouri.
Other psychiatric/mental health in Kansas City
- Edward AvilesKansas City$6K
- Redempta BekahKansas City$6K
- Aldijana SacicSaint Louis$510K
- Erin DuvallSpringfield$275K
- Laurel OwensLees Summit$246K
- Julie WaterburySaint Louis$135K
- Emily WoukSpringfield$90K
- Kristerpher BrimberryPoplar Bluff$74K
- Matthew LindquistSt Louis$42K
- Stacy EmersonKennett$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.